These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30014208)

  • 1. Emerging Treatments in Episodic Migraine.
    Grimsrud KW; Halker Singh RB
    Curr Pain Headache Rep; 2018 Jul; 22(9):61. PubMed ID: 30014208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic approaches for the prevention and treatment of migraine.
    Diener HC; Charles A; Goadsby PJ; Holle D
    Lancet Neurol; 2015 Oct; 14(10):1010-22. PubMed ID: 26376968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Medications for the Treatment of Migraine.
    Ceriani CEJ; Wilhour DA; Silberstein SD
    Headache; 2019 Oct; 59(9):1597-1608. PubMed ID: 31559638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
    Ailani J; Burch RC; Robbins MS;
    Headache; 2021 Jul; 61(7):1021-1039. PubMed ID: 34160823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
    Pellesi L; Guerzoni S; Pini LA
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatments for the primary headache disorders.
    Schuster NM; Vollbracht S; Rapoport AM
    Neurol Sci; 2015 May; 36 Suppl 1():109-13. PubMed ID: 26017524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Treatment for Episodic Migraine.
    Parikh SK; Silberstein SD
    Neurol Clin; 2019 Nov; 37(4):753-770. PubMed ID: 31563231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies for the treatment and prevention of primary headache disorders.
    Schuster NM; Rapoport AM
    Nat Rev Neurol; 2016 Oct; 12(11):635-650. PubMed ID: 27786243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGRP antagonists for decreasing migraine frequency: New options, long overdue.
    Bucklan J; Ahmed Z
    Cleve Clin J Med; 2020 Apr; 87(4):211-218. PubMed ID: 32238376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on migraine: current understanding and future directions.
    Puledda F; Messina R; Goadsby PJ
    J Neurol; 2017 Sep; 264(9):2031-2039. PubMed ID: 28321564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
    Levin M; Silberstein SD; Gilbert R; Lucas S; Munsie L; Garrelts A; Kennedy K; Everman N; Pearlman E
    Headache; 2018 Nov; 58(10):1689-1696. PubMed ID: 30426478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Therapeutic Impact of New Migraine Discoveries.
    Vécsei L; Lukács M; Tajti J; Fülöp F; Toldi J; Edvinsson L
    Curr Med Chem; 2019; 26(34):6261-6281. PubMed ID: 29848264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erenumab in the treatment of migraine.
    Jain S; Yuan H; Spare N; Silberstein SD
    Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging target-based paradigms to prevent and treat migraine.
    Silberstein SD
    Clin Pharmacol Ther; 2013 Jan; 93(1):78-85. PubMed ID: 23212108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants.
    Do TP; Al-Saoudi A; Ashina M
    Rev Neurol (Paris); 2021 Sep; 177(7):827-833. PubMed ID: 34294458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Devices for Episodic Migraine: Past, Present, and Future.
    Moreno-Ajona D; Hoffmann J; Akerman S
    Curr Pain Headache Rep; 2022 Mar; 26(3):259-265. PubMed ID: 35147856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.